Company Filing History:
Years Active: 2013-2022
Title: Christine Günther: Innovator in Stem Cell Research
Introduction
Christine Günther is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of stem cell research, particularly in the development of innovative methods for treating tumors and expanding stem cells. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
One of her latest patents focuses on genetically modified mesenchymal stem cells that express an immune response-stimulating cytokine. This invention aims to attract and activate immune cells to treat tumors effectively. The method involves administering genetically modified mesenchymal stem cells that include exogenous nucleic acid molecules encoding immune response-stimulating cytokines such as IL-7, IL-12, or IL-21.
Another significant patent by Christine Günther is related to an expansion medium for CD34-negative stem cells. This invention provides a cell growth medium that includes human platelet lysate, human fresh frozen plasma filtrate, heparin, L-glutamine, and a serum-free, low glucose medium. The medium is designed to permit the expansion of human CD34 stem cells while retaining their ability to differentiate.
Career Highlights
Christine has worked with notable companies in the biomedical field, including Junctucell Biomed Manufacturing GmbH and Apceth GmbH & Co. KG. Her experience in these organizations has contributed to her expertise in stem cell research and development.
Collaborations
Throughout her career, Christine has collaborated with talented individuals such as Stefanos Theoharis and Felix Hermann. These partnerships have enhanced her research and innovation efforts in the field.
Conclusion
Christine Günther is a trailblazer in stem cell research, with her innovative patents and collaborations driving advancements in medical treatments. Her work continues to inspire future innovations in the field.